KEY FEATURES
Full Name | Clusterin |
---|---|
Synonym | APO-J;APOJ;CLI;KUB1;NA1/NA2;SGP2;SP-40;TRPM2; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 12.5-800ng/mL |
Sensitivity | 5.1ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CLU in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CLU. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CLU and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CLU, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CLU. You can calculate the concentration of Human CLU in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CLU ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 41.07 | 76.94 | 320.52 | 40.57 | 71.94 | 328.28 |
Standard deviation | 2.21 | 4.45 | 14.97 | 2.84 | 3.29 | 13.66 |
CV(%) | 5.39 | 5.79 | 4.67 | 7 | 4.58 | 4.16 |
RECOVERY
The recovery of Human CLU spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 87-100 | 93 |
EDTA plasma (n=8) | 85-97 | 91 |
Cell culture media (n=8) | 94-109 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CLU in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CLU ELISA Kits
APP ELISA Kit | publications with CLU and APP |
TGFB1 ELISA Kit | publications with CLU and TGFB1 |
EGF ELISA Kit | publications with CLU and EGF |
UBC ELISA Kit | publications with CLU and UBC |
FN1 ELISA Kit | publications with CLU and FN1 |
VHL ELISA Kit | publications with CLU and VHL |
ALB ELISA Kit | publications with CLU and ALB |
Pathways associated with CLU ELISA Kit
Hemostasis Pathway | Hemostasis Pathway |
Platelet Activation, Signaling And Aggregation Pathway | Platelet Activation, Signaling And Aggregation Pathway |
Platelet Degranulation Pathway | Platelet Degranulation Pathway |
Response To Elevated Platelet Cytosolic Ca2+ Pathway | Response To Elevated Platelet Cytosolic Ca2+ Pathway |
Validated Targets Of C-MYC Transcriptional Repression Pathway | Validated Targets Of C-MYC Transcriptional Repression Pathway |
Diseases associated with CLU ELISA Kit
Nervous System Diseases | publications with CLU and Nervous System Diseases |
Brain Diseases | publications with CLU and Brain Diseases |
Alzheimer Disease | publications with CLU and Alzheimer Disease |
Prostatic Neoplasms | publications with CLU and Prostatic Neoplasms |
Kidney Diseases | publications with CLU and Kidney Diseases |
Cardiovascular Diseases | publications with CLU and Cardiovascular Diseases |
Disease Models, Animal | publications with CLU and Disease Models, Animal |
Adenocarcinoma | publications with CLU and Adenocarcinoma |
Necrosis | publications with CLU and Necrosis |
Breast Neoplasms | publications with CLU and Breast Neoplasms |
Organs/Tissues associated with CLU ELISA Kit
Blood | publications with CLU and Blood |
Brain | publications with CLU and Brain |
Prostate | publications with CLU and Prostate |
Kidney | publications with CLU and Kidney |
Nerve | publications with CLU and Nerve |
Liver | publications with CLU and Liver |
Vascular | publications with CLU and Vascular |
Eye | publications with CLU and Eye |
Testis | publications with CLU and Testis |
Lung | publications with CLU and Lung |